New study tests coaching to boost Pill-Taking in young cancer patients

NCT ID NCT07223463

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study tests whether a tailored coaching program can help adolescents and young adults (ages 15-24) with cancer take their oral medications as prescribed. Participants will work with a coach over four sessions to identify and overcome barriers to adherence, using an electronic pill bottle to track progress. The study will compare this personalized approach to a standard text-message feedback program, measuring adherence, quality of life, and healthcare use.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Tailored behavioral coaching program
What this could lead to
If it works, this could provide a practical way to help young cancer patients stick to their medication schedules, potentially improving treatment outcomes and quality of life.
What could go wrong
This is a small, early-stage behavioral study with no drug involved, so results may not be dramatic or widely applicable. Success depends on participant engagement and may not translate to other settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Medication Adherence neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Columbia University Irving Medical Center

    New York, New York, 1003230702, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

  • The University of Kansas Medical Center

    Kansas City, Kansas, 66160, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.